132 related articles for article (PubMed ID: 29429436)
1. Burkitt's lymphoma: The prevalence of HIV/AIDS and the outcome of treatment.
Hesseling PB; Kouya F; Katayi E; Mbah G; Wharin P
S Afr Med J; 2018 Feb; 108(2):84-85. PubMed ID: 29429436
[TBL] [Abstract][Full Text] [Related]
2. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
3. Burkitt's lymphoma shortly after an acute HIV infection, treated with highly active retroviral treatment.
Colebunders R; Dohmen S; Van de Velde A; Pelgrom J; Hermans P
Acta Clin Belg; 2001; 56(5):321-2. PubMed ID: 11770227
[No Abstract] [Full Text] [Related]
4. [Clinical study of 40 children with Burkitt's and Burkitt-like lymphoma].
Zhang YH; Duan YL; Yang J; Jin L; Zhou CJ; Gao ZF
Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):209-14. PubMed ID: 19099711
[TBL] [Abstract][Full Text] [Related]
5. Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma.
Montoto S; Wilson J; Shaw K; Heath M; Wilson A; McNamara C; Orkin C; Nelson M; Johnson M; Bower M; Cwynarski K
AIDS; 2010 Mar; 24(6):851-6. PubMed ID: 20124971
[TBL] [Abstract][Full Text] [Related]
6. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
[TBL] [Abstract][Full Text] [Related]
7. Short communication: spectrum of non-Hodgkin lymphoma in an urban Ryan White-funded clinic in the established antiretroviral era.
Silverton A; Gunthel C; Adamski M; Mosunjac M; Nguyen ML
AIDS Res Hum Retroviruses; 2014 Jul; 30(7):665-9. PubMed ID: 24707838
[TBL] [Abstract][Full Text] [Related]
8. Burkitt's lymphoma treatment in a rural hospital in Sierra Leone.
San Roman M; Aguilo F; Clapes M; Sheku M; Dawoh P; Mora J; Cruz O
Trans R Soc Trop Med Hyg; 2013 Oct; 107(10):653-9. PubMed ID: 24021903
[TBL] [Abstract][Full Text] [Related]
9. Adult Burkitt's lymphoma in patients with and without human immunodeficiency virus infection in Kenya.
Otieno MW; Remick SC; Whalen C
Int J Cancer; 2001 Jun; 92(5):687-91. PubMed ID: 11340573
[TBL] [Abstract][Full Text] [Related]
10. [Maxillofacial location of Burkitt's lymphoma in children treated at the University Hospital Center in Bamako, Mali: a 24-case series].
Togo B; Keita M; Medefo D; Traore F; Sidibe T
Med Trop (Mars); 2008 Dec; 68(6):600-2. PubMed ID: 19639827
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Burkitt's lymphoma in HIV-positive patients.
Straus DJ
Biomed Pharmacother; 1996; 50(9):447-50. PubMed ID: 8991116
[TBL] [Abstract][Full Text] [Related]
12. Aspects of epidemiological and clinical features of patients with central nervous system Burkitt's lymphoma in Kenya.
Mwanda OW
East Afr Med J; 2004 Aug; (8 Suppl):S97-103. PubMed ID: 15622608
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract][Full Text] [Related]
14. Durable survival after chemotherapy in a HIV patient with Burkitt's lymphoma presenting with massive upper gastrointestinal bleeding.
Law MF; Chan HN; Pang CY; Lai HK; Ha CY; Ng C; Ho R; Wong CK; Yeung YM; Yip SF
Int J STD AIDS; 2016 Jul; 27(8):690-6. PubMed ID: 26185043
[TBL] [Abstract][Full Text] [Related]
15. Malignancies in HIV-infected children at Siriraj Hospital.
Sanpakit K; Veerakul G; Kriengsuntornkij W; Chokephaibulkit K; Tanphaichitr VS; Mahasandana C
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S542-8. PubMed ID: 12403230
[TBL] [Abstract][Full Text] [Related]
16. Oro-facial manifestations of Burkitt's lymphoma: an analysis of 680 cases from Malawi.
Mlotha J; Naidoo S
SADJ; 2011 Mar; 66(2):77-9. PubMed ID: 21608501
[TBL] [Abstract][Full Text] [Related]
17. Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.
Oriol A; Ribera JM; Esteve J; Sanz MA; Brunet S; Garcia-Boyero R; Fernández-Abellán P; Martí JM; Abella E; Sánchez-Delgado M; Peñarrubia MJ; Besalduch J; Moreno MJ; Borrego D; Feliu E; Ortega JJ;
Haematologica; 2003 Apr; 88(4):445-53. PubMed ID: 12681972
[TBL] [Abstract][Full Text] [Related]
18. Rescue chemotherapy for patients with resistant or relapsed endemic Burkitt's lymphoma.
Hesseling PB; Molyneux E; Kamiza S; Broadhead R
Trans R Soc Trop Med Hyg; 2008 Jun; 102(6):602-7. PubMed ID: 18417177
[TBL] [Abstract][Full Text] [Related]
19. Treating Burkitt's lymphoma in Malawi, Cameroon, and Ghana.
Hesseling PB; Molyneux E; Tchintseme F; Welbeck J; McCormick P; Pritchard-Jones K; Wagner HP
Lancet Oncol; 2008 Jun; 9(6):512-3. PubMed ID: 18510986
[No Abstract] [Full Text] [Related]
20. The Cameroon 2008 Burkitt lymphoma protocol: improved event-free survival with treatment adapted to disease stage and the response to induction therapy.
Hesseling PB; Njume E; Kouya F; Katayi T; Wharin P; Tamannai M; Achu P; Kidd M; McCormick P
Pediatr Hematol Oncol; 2012 Mar; 29(2):119-29. PubMed ID: 22376015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
